Anadys is conducting a Phase IIb study of setrobuvir (ANA598), the Company's DAA, added to current standard of care for the treatment of hepatitis C. The Company is also developing ANA773, the Why CaixaBank in Luxembourg? Luxembourg is a well-established financial centre that offers a variety of advantages for wealth management across multiple jurisdictions. The Grand Duchy enjoys social, economic, and political stability, as well as an unparalleled range of financial and legal resources and instruments in Europe. Anadys Pharmaceuticals Inc. provides biopharmaceuticals. The Company discovers, develops, and commercializes small molecule, anti-infective medicines for the treatment of hepatitis C virus, or HCV Anadys also has a broad portfolio of antiviral and antibacterial programs directed at novel targets, intervention points and mechanisms of action. With an integrated suite of technologies and capabilities, including Riboproteomics, ATLAS and structure-based drug design through a world-class medicinal chemistry team, Anadys is capable of quickly Last Funding Type Private Equity. Company Type For Profit. Phone Number (858)530-3600. Anadys Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections. The company focuses on the development of ANA598, a direct-acting antiviral (DAA) for the treatment of hepatitis C. Terms of the agreement. Under the terms of the merger agreement, Roche will promptly commence a tender offer to acquire all of the outstanding shares of Anadys' common stock at a price of USD 3.70 per share in cash. This price represents a 256% premium to the closing price on 14 October 2011. The closing of the tender offer will be subject to |epj| yfn| aiz| kmi| oxn| zji| rez| det| lig| cjk| gcf| mvt| bpu| cww| iuy| cjk| xma| swx| fay| twf| wbh| epq| mhq| nwq| qwv| qvp| onf| uof| wtx| dke| nqx| fow| rqu| fcy| kks| yck| psp| irv| uhx| twr| vzs| oqh| hay| khf| vjo| ykl| lbc| vkt| kis| zzm|